Thursday 31st December 2009 |
Text too small? |
Fonterra Cooperative Group, the world’s biggest dairy exporter, said its joint venture with Royal FrieslandCampina will acquire the Dutch milk products group’s pharmaceutical lactose business for about $106 million.
Fonterra’s share of the purchase price is $53 million, the cooperative said in a statement today. The DMV-Fonterra Excipients JV will acquire the FrieslandCampina Domo-Pharma unit subject to regulatory approvals in a deal expected by March, it said.
The transaction will add value to Fonterra by creating a larger scale pharmaceutical lactose business, said Andrei Mikhalevsky, managing director for ingredients. The deal would combine the two companies’ R&D capabilities, he said.
Businesswire.co.nz
No comments yet
Fonterra appoints permanent COO
Manawa Energy FY24 Annual Results & Webcast Details
Seeka Provides the Results of Meeting - ASM
April 19th Morning Report
PGW Guidance Update
CNU - Commerce Commission releases draft expenditure decision
Spark announces departure of Product Director
TGG - T&G appoints new Director
April 18th Morning Report
SKC - APPOINTMENT OF CHIEF EXECUTIVE OFFICER